RESUMEN
Objective:To investigate the clinicopathological features, immunohistochemical phenotypes and molecular characteristics of adenosquamous carcinoma of the lung(ASC)in elderly patients.Methods:Clinical data of 72 ASC patients in the Department of Pathology, The Second Affiliated Hospital of Soochow University from January 2009 to December 2020 were retrospectively analyzed, and 48 patients aged ≥60 years were selected.Clinical manifestations, imaging findings, histopathological and immunohistochemical characteristics were collected, and gene mutations were detected by the amplification refractory mutation system(ARMS-PCR).Results:There were 48 patients including 32 males and 16 females with a mean age of 70 years(range: 60-84 years). The maximum diameters of the tumors ranged from 0.3 to 9.0 cm(mean: 2.8 cm). Microscopically, the tumors contained two components, squamous cell carcinoma and adenocarcinoma, with the squamous cell carcinoma tissue showing intercellular bridges and the adenocarcinoma tissue showing papillary, acinar or tubular structures.Immunohistochemistry assays detected varying expression levels of CK7(30/31), CK5/6(20/28), TTF1(12/31), P40(15/17), and P63(12/13). Molecular testing showed that the EGFR mutation rate was 58.8%(10/17)and the ALK fusion mutation rate was 5.9%(1/17), while ROS1 and MET mutations were not detected.All 48 patients underwent surgical resection.Conclusions:ASC cases are relatively rare and prone to misdiagnosis.The diagnosis requires the combination of HE morphology, immunohistochemistry and imaging examination, and surgery is the main treatment option.The mutation rate of the EGFR gene is relatively high in ASC patients.
RESUMEN
Objective @#To investigate the expression and clinical significance of erbb2 interacting protein (ERBIN) and PDZ domain containing 2 protein (PDZD2) in colorectal cancer tissues，as well as the effects of ERBIN and PDZD2 on the progression of colorectal cancer and the corresponding mechanisms．@*Methods @#Western blot was used to detect the expression of ERBIN and PDZD2 proteins in tumor tissues and corresponding adjacent tissues from 86 colorectal cancer patients，as well as normal human colon fibroblasts ( CCD-18Co) and human colorectal cancer cell lines ( SW480 ，HCT116 ，SW620 and HT29 ) ; SW620 and HCT116 cells were transfected with ERBIN or PDZD2 overexpression vector，and then cell proliferation，cell invasion and apoptosis were detected．The expres- sion of ERBIN or PDZD2 protein in SW620 cell was observed by immunofluorescence chemistry．Co-immunoprecip- itation assay was used to detect the interaction between ERBIN and PDZD2 proteins.@*Results @#The expression levels of ERBIN and PDZD2 proteins in colorectal cancer tissues were lower than those in adjacent tissues (P＜0．01) ， and the expression levels of ERBIN and PDZD2 in colorectal cancer cells were lower than those in CCD-18Co cells (P＜0. 01) ．The expression levels of ERBIN and PDZD2 proteins were correlated with the depth of invasion，dif- ferentiation，TNM staging and lymph node metastasis of colorectal cancer (P＜0. 001) ; ERBIN or PDZD2 overex- pression reduced the proliferation and invasion of SW620 and HCT116 cells (P＜0. 01) ，increased cell apoptosis (P ＜0. 01 ) ; ERBIN directly bound to PDZD2 ，and overexpression of ERBIN increased the expression level of PDZD2 protein．@*Conclusion @#ERBIN can inhibit the proliferation and invasion of colorectal cancer cells and pro- mote apoptosis by promoting the expression of PDZD2 protein.